click below
click below
Normal Size Small Size show me how
WEEK 5:
Theories of Drug Action - at receptors:
| Question | Answer |
|---|---|
| receptor | proteins which respond to endogenous messenger by initiating signal |
| what can bind to a receptor (7) | metal ions, AA, lipids, protein hormones, gases, biogenic amines, peptides |
| what biogenic amines can bind to receptors | ACh + adrenaline |
| what gases can bind to receptors | nitric oxide |
| what are the main superfamilies of receptors (4) | ligand gated ion channels, g protein couple receptors, catalytic receptors, nuclear receptors |
| order the four main receptors from fastest to slowest | ligand gated ion channels (ms), g protein couples receptors (sec-min), catalytic receptors (min-hour), nuclear receptors (hr-day) |
| explain how receptors act as molecular switches | switch between inactive (R) and active (R*) states |
| what do inhibitors act on | enzymes, transporters, ion channels |
| what do agonists/antagonists act on | receptors |
| affinity | ability of a drug to bind to receptor |
| how is affinity represented | D+R (unbound) ⇌ DR (inactive) |
| efficacy | once bound, ability of drug to activate receptor by conformational change |
| how is efficacy represented | DR (inactive) ⇌ DR* (active) -> response |
| agonist | binds + activates target (has both affinity + efficacy) |
| antagonist | binds + blocks target (only has affinity) |
| drug binding obeys what law | law of mass action |
| law of mass action | rates of binding are proportional to concentration (so the more drug/ receptor you have the more likely they will bump into each other and bind) |
| forward rate equation | Kon [D][R] |
| Kon | association rate constant |
| reverse rate equation | Koff [D][R] |
| Koff | dissociation rate constant |
| Kd | equilibrium dissociation constant/ concentration of drug needed to occupy 50% receptors |
| Kd equation in terms of drug and receptor | [D][R] / [DR] |
| Kd equation in terms of receptor occupancy | [D](1-α)/ α |
| receptor occupancy represented as what | α |
| α formula | [D]/ [D] +Kd |
| what does D + R ⇌ DR represent in receptor occupancy | D + R (1-α) ⇌ DR (α) |
| receptor occupancy equation | α = [D] /[D] + Kd |
| what is the concentration of D equal to | Kd |
| SAR in words | structure activity relationships |
| SAR | the link between drug structure changes and their effect on target |
| discuss adrenoceptors in salbutamol | 1 micrometre affinity in B2, 10 micrometre affinity in B1 (has a 10 fold B2/B1 selectivity) |
| discuss adrenoceptors in formoterol | 0.01 micrometre affinity in B2, 1 micrometre affinity in B1 (has a 100 fold B2/B1 selectivity) |
| what does Kd help quantify and how can it be measured | numerical measure of affinity measured using Kd eg radioligand binding |
| compare salbutamol and formoterol | formoterol has 100 fold higher affinity for airway adrenoceptors than salbutamol, meaning it is more selective (less it needed) |
| on concentration response curve what does the Y axis represent | response |
| on concentration response curve what does the X axis represent | concentration= (Log (M) |
| Rmax | max response (effect) drug has even if you add more (efficacy) |
| Ec50 | effective concentration of drug that produces 50% maximum response (potency) |
| what do adrenaline and salmeterol look like on a concentration response curve | adrenaline higher than salmeterol (adrenaline has 100% airway, 10^-6M EC50 and salmeterol has 50% airway smooth muscle relaxation, 10^-8M EC50) |
| adrenaline Rmax | 100% |
| adrenaline EC50 | 10^-6 M |
| salmeterol Rmax | 50% |
| salmeterol EC50 | 10^-8 M |
| compare potency in salmeterol and adrenaline | salmeterol is 100 fold more potent than adrenaline |
| compare efficacy in salmeterol and adrenaline | salmeterol has a lower efficacy so is a partial agonist compared to adrenaline for airway relaxation |
| what do values (EC50 + Rmax) in concentration response curves depend on | drug receptor interaction (affinity + efficacy) + properties of functional response- amplification (how cells amplify signal) |
| receptor reserve | maximum response can be made with only a few receptors activated so not all occupied |
| many antagonists are what | competitive and reversible |
| what does it mean if antagonist is reversible | binds non covalently + can dissociate from receptor |
| describe the effect of antagonists on EC50 and Rmax | potency reduced but not Rmax |
| competitive antagonists | bind to same 3D binding site on target receptor as agonist (so share same structural similarities) |
| how does formoterol concentration response curve shift when antagonist (propranolol) is added | shifts right (changes EC50 but same Rmax) |
| where do non competitive antagonists bind | different (allosteric) site from agonist receptor |
| example of non competitive antagonists | memantine |
| how are competitive antagonists surmountable | add more agonist to overcome inhibition |
| how are non competitive anatagonists non surmountable | even if add more agonist it will not overcome inhibition |
| describe the concentration response curve for glutamate (agonist) affected by 1micrmetre of memantine (antagonist) | decrease Rmax from 100% to 50% + reduces efficacy |
| describe how memantine (non competitive antagonist) works againts glutamine (agonist) and NMDA (ligand gated ion channel) | usually glutamate binds to NMDA outside so Na+ and Ca2+ flow inside but memantine binds inside channel pore = blocks flow so even if more glutamate binds receptor no work |
| glutamate | agonist |
| memantine | antagonist |